<?xml version="1.0" encoding="UTF-8"?>
<p id="par0095">Inovio Pharmaceutical developed INO-4800 which is in phase 1 trials showed safe and protective immunity. LV- SMENP- DC from Shenzhen Geno-Immune Medical Institute (phase1) may offer promising vaccines against COVID-19.</p>
